Sign in
Download Opera News App

Health

 

Health Living

 

Disease prevention and treatment

Finally Good News for HIV Positive people

Finally, some good news for HIV-positive people

Islatravir is clearly available for distribution in Zimbabwe, Malawi, South Africa, Uganda, and the United States before the end of the year.

Because the medicine has a long-lasting effect on the body, it is usually given to patients once a month. The drug will go a long way toward alleviating the medication sluggishness that HIV positive people experience. HIV-positive people occasionally fail to take their prescriptions, particularly in the case of children who are not cared for by adults.

Islatravir isn't the only one facing charges; Cabenuva is also being tried once a month in Kenya.

Apart from these two, dolutegravir is another pharmaceutical on the way, but it will most likely be significantly better one year from now or in 2023, because dolutegravir can only be used once per year. Another tablet in the works is cabotegravir, which must be taken once a day like clockwork but is now being tested.

Sources;

https://www.google.com/url?sa=t&source=web&rct=j&url=https://viivhealthcare.com/en-gb/our-stories/innovation-hiv-science/towards-a-cure-exploring-cure-and-remission-in-hiv/&ved=2ahUKEwje4uWp667zAhVP_rsIHS6XAWIQo7QBegQICxAB&usg=AOvVaw1h_Rv-Mkc6eQZvS3J53djO

Content created and supplied by: Darex (via Opera News )

HIV-positive Islatravir South Africa Uganda United States

COMMENTS

Load app to read more comments